Evofem Biosciences Inc Investor Call Transcript
Good afternoon and welcome to the Evofem Biosciences investor update call. I'll turn the call over to Amy Raskopf, Evofem Biosciences' Vice President of Investor Relations.
Thank you all for joining us this afternoon. Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, August 11, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q.
With that, I'll turn the call over to Evofem's CEO, Saundra Pelletier.
Thank you for joining the call today. The purpose of the call is to provide clarity on the listing of Evofem's common stock and our future plans. On Tuesday afternoon, we were notified at the Nasdaq Hearings Panel's decision to delist our shares
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
